About Sagar Nigwekar, MBBS, MD

Departments, Centers, & Programs:

Clinical Interests:

Treats:

Languages:

Locations

Mass General Renal Associates
165 Cambridge Street
Suite 302
Boston, MA 02114
Phone: 617-726-5050

Medical Education

  • MD, Seth G. S. Medical College
  • Residency, Rochester General Hospital
  • Fellowship, Brigham and Women's Hospital

American Board Certifications

  • Internal Medicine, American Board of Internal Medicine
  • Nephrology, American Board of Internal Medicine

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.


Research

My research is primarily focused on the areas of calcific uremic arteriolopathy (CUA), a.k.a. calciphylaxis and vascular calcification in dialysis patients.

CUA, a dermal arteriolar calcification disorder seen in dialysis patients, has significant morbidity associated with complicated wounds and non-remitting pain and 60-80% one-year mortality. During my nephrology training, I saw many CUA cases and was astounded by the unmet research needs in the CUA field linked to: 1) Unclear pathogenesis and risk factors, 2) Non-existence of circulating diagnostic biomarkers considering the risk of non-healing ulceration from skin biopsy (the current diagnostic gold-standard) and, 3) Absence of effective therapy.

I am interested in understanding the risk factors and pathobiology of CUA, and to develop and examine strategies to effectively diagnose and treat CUA. In addition, I aim to apply the knowledge gained from CUA research to investigate other forms of vascular calcifications in dialysis patients. Over 70% of dialysis patients have coronary artery, aortic or valvular calcifications, and recent literature attributes 50% of cardiovascular deaths in dialysis patients to vascular calcifications. Although, Virchow described the predisposition to vascular calcifications in kidney disease over a century ago, the biology of vascular calcification remains unclear and this limits development and evaluation of treatment interventions. I believe that CUA research will serve as a high-speed template to understand the biology of vascular calcification and accelerate the T2 translational research in this field.

Publications

Reviews: Comments and Ratings

4.9out of 5(54 Ratings, 33 Comments)

February 2025

Dr. Nigwekar was very attentive, he was thorough, and he was very engaging. He listened carefully and I highly recommend him. In addition, his fellow, Dr. [redacted], was also extremely engaging and attentive to detail and I would highly recommend him as well. Thank you very much.


January 2025

Provider is very knowledgeable, Personable, approachable and a great listener.


January 2025

Nothing else to say but thank you


December 2024

I cannot say enough about Dr. N and his staff. I went to him with an extremely difficult and challenging problem, and he was able to work through it not only with his team there, but the dermatology department and my other team of doctors closer to home. Thank you very much.


December 2024

The doctor is a wonderful practitioner. He is kind and caring.


December 2024

A wonderful kind and competent provider. Lucky to have him.


October 2024

Dr. Nigwekar as always was wonderful. I had a lot of serious medical issues to talk with him about and he does a great job collaborating with my other specialists and providing me expert advice. He follows me very closely due to my CKD and is always available to me. I feel very fortunate to have him as my physician.


October 2024

I found this doctor to be exceptional. He explained things to my husband, my daughter, and myself very clearly, spoke very well, and so far he's great. He is really great. I'm so glad that I decided to go to him to see him. He was wonderful.


October 2024

This provider has always treated me with quality care and provided knowledgeable information for me


October 2024

Very good. Answered all the questions that we needed to be answered and explained everything in detail.

View More
Ratings and Comments Powered by NRC Health